Mohammad Alzrigat

8PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2026
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.

|Nov 16, 2024
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma.

Muhammad Mushtaq, Judit Liaño-Pons, Jiansheng Wang

|Sep 28, 2023
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.

Ye Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia

|May 13, 2023
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma.

Prasoon Agarwal, Aleksandra Glowacka, Loay Mahmoud

|Mar 06, 2023
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.

Alina Castell, Qinzi Yan, Karin Fawkner

|Mar 02, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.

Daniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset

Pageof 2

Frequent Collaborators

2 joint publications

Ruining Liu

2 joint publications

Victoria Muliadi

2 joint publications

Hanxiong Li

2 joint publications

Benedict J Chambers